These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36768696)

  • 21. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
    Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
    Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples.
    Lam C; Gray K; Gall M; Sadsad R; Arnott A; Johnson-Mackinnon J; Fong W; Basile K; Kok J; Dwyer DE; Sintchenko V; Rockett RJ
    J Clin Microbiol; 2021 Oct; 59(11):e0104621. PubMed ID: 34379527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity of sample processing methods impacts wastewater SARS-CoV-2 whole genome amplicon sequencing outcomes.
    Feng S; Owens SM; Shrestha A; Poretsky R; Hartmann EM; Wells G
    Sci Total Environ; 2023 Jun; 876():162572. PubMed ID: 36871720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program.
    Lau KA; Foster CSP; Theis T; Draper J; Sullivan MJ; Ballard S; Rawlinson WD
    Pathology; 2024 Aug; 56(5):717-725. PubMed ID: 38729860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.
    Coolen JPM; Wolters F; Tostmann A; van Groningen LFJ; Bleeker-Rovers CP; Tan ECTH; van der Geest-Blankert N; Hautvast JLA; Hopman J; Wertheim HFL; Rahamat-Langendoen JC; Storch M; Melchers WJG
    J Clin Virol; 2021 Nov; 144():104993. PubMed ID: 34619382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes.
    Baker DJ; Aydin A; Le-Viet T; Kay GL; Rudder S; de Oliveira Martins L; Tedim AP; Kolyva A; Diaz M; Alikhan NF; Meadows L; Bell A; Gutierrez AV; Trotter AJ; Thomson NM; Gilroy R; Griffith L; Adriaenssens EM; Stanley R; Charles IG; Elumogo N; Wain J; Prakash R; Meader E; Mather AE; Webber MA; Dervisevic S; Page AJ; O'Grady J
    Genome Med; 2021 Feb; 13(1):21. PubMed ID: 33563320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Illumina® COVIDSeq™ as a tool for Omicron SARS-CoV-2 characterisation.
    Lowry K; Bauer MJ; Buckley C; Wang C; Bordin A; Badman S; Harris PNA; Mackay I; Whiley D
    J Virol Methods; 2023 Dec; 322():114827. PubMed ID: 37778540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq.
    Tshiabuila D; Giandhari J; Pillay S; Ramphal U; Ramphal Y; Maharaj A; Anyaneji UJ; Naidoo Y; Tegally H; San EJ; Wilkinson E; Lessells RJ; de Oliveira T
    BMC Genomics; 2022 Apr; 23(1):319. PubMed ID: 35459088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Genomic Surveillance of SARS-CoV-2 Virus on Illumina Sequencing Platforms in the Slovak Republic-One Year Experience.
    Rusňáková D; Sedláčková T; Radvák P; Böhmer M; Mišenko P; Budiš J; Bokorová S; Lipková N; Forgáčová-Jakúbková M; Sládeček T; Sitarčík J; Krampl W; Gažiová M; Kaliňáková A; Staroňová E; Tichá E; Vrábľová T; Ševčíková L; Kotvasová B; Maďarová L; Feiková S; Beňová K; Reizigová L; Onderková Z; Ondrušková D; Loderer D; Škereňová M; Danková Z; Janíková K; Halašová E; Nováková E; Turňa J; Szemes T
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchmarking and Assessment of Eight
    Gupta AK; Kumar M
    OMICS; 2022 Jul; 26(7):372-381. PubMed ID: 35759429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation Sequencing.
    Li T; Chung HK; Pireku PK; Beitzel BF; Sanborn MA; Tang CY; Hammer RD; Ritter D; Wan XF; Maljkovic Berry I; Hang J
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33653700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights.
    Nagy-Szakal D; Couto-Rodriguez M; Wells HL; Barrows JE; Debieu M; Butcher K; Chen S; Berki A; Hager C; Boorstein RJ; Taylor MK; Jonsson CB; Mason CE; O'Hara NB
    Microbiol Spectr; 2021 Oct; 9(2):e0019721. PubMed ID: 34468193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance.
    Liu D; Wang Z; Mao M; Zhang Z; Ding X; Zheng H; Li S; Zhang Z; Tian Z
    J Med Virol; 2023 Nov; 95(11):e29222. PubMed ID: 37964661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
    Borillo GA; Kagan RM; Marlowe EM
    Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.
    Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW
    Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.
    Charre C; Ginevra C; Sabatier M; Regue H; Destras G; Brun S; Burfin G; Scholtes C; Morfin F; Valette M; Lina B; Bal A; Josset L
    Virus Evol; 2020 Jul; 6(2):veaa075. PubMed ID: 33318859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanopore sequencing of SARS-CoV-2: Comparison of short and long PCR-tiling amplicon protocols.
    Brejová B; Boršová K; Hodorová V; Čabanová V; Gafurov A; Fričová D; Neboháčová M; Vinař T; Klempa B; Nosek J
    PLoS One; 2021; 16(10):e0259277. PubMed ID: 34714886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing.
    Van Poelvoorde LAE; Delcourt T; Coucke W; Herman P; De Keersmaecker SCJ; Saelens X; Roosens NHC; Vanneste K
    Front Microbiol; 2021; 12():747458. PubMed ID: 34721349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
    Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
    BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.